The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
p38 MAPK inhibition: A promising therapeutic approach for COVID-19
Open accessAbstract
COVID-19, caused by the SARS-CoV-2 virus, is a major source of morbidity and mortality due to its inflammatory effects in the lungs and heart. The p38 MAPK pathway plays a crucial role in the release of pro-inflammatory cytokines such as IL-6 and has been implicated in acute lung injury and myocardial dysfunction. The overwhelming inflammatory response in COVID-19 infection may be caused by disproportionately upregulated p38 activity, explained by two mechanisms. First, angiotensin-converting enzyme 2 (ACE2) activity is lost during SARS-CoV-2 viral entry. ACE2 is highly expressed in the lungs and heart and converts Angiotensin II into Angiotensin 1-7. Angiotensin II signals proinflammatory, pro-vasoconstrictive, pro-thrombotic activity through p38 MAPK activation, which is countered by Angiotensin 1-7 downregulation of p38 activity. Loss of ACE2 upon viral entry may tip the balance towards destructive p38 signaling through Angiotensin II. Second, SARS-CoV was previously shown to directly upregulate p38 activity via a viral protein, similar to other RNA respiratory viruses that may hijack p38 activity to promote replication. Given the homology between SARS-CoV and SARS-CoV-2, the latter may employ a similar mechanism. Thus, SARS-CoV-2 may induce overwhelming inflammation by directly activating p38 and downregulating a key inhibitory pathway, while simultaneously taking advantage of p38 activity to replicate. Therapeutic inhibition of p38 could therefore attenuate COVID-19 infection. Interestingly, a prior preclinical study showed protective effects of p38 inhibition in a SARS-CoV mouse model. A number of p38 inhibitors are in the clinical stage and should be considered for clinical trials in serious COVID-19 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 1×
“ACE2 is present in multiple tissues and is highly expressed in the lungs and heart [2].”
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1643-8 · Cited by 2,031
Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882
Activation and signaling of the p38 MAP kinase pathway
ZARUBIN, T., & HAN, J. (2005) · Cell Research · doi:10.1038/sj.cr.7290257 · Cited by 1,707
Zhang, P., Zhu, L., Cai, J., Lei, F., Qin, J.-J., Xie, J., Liu, Y.-M., Zhao, Y.-C., Huang, X., Lin, L., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317134 · Cited by 1,133
ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis
Simões e Silva, A., Silveira, K., Ferreira, A., & Teixeira, M. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12159 · Cited by 542
Ma, X. L., Kumar, S., Gao, F., Louden, C. S., Lopez, B. L., Christopher, T. A., Wang, C., Lee, J. C., Feuerstein, G. Z., & Yue, T.-L. (1999) · Circulation · doi:10.1161/01.cir.99.13.1685 · Cited by 501
Koka, V., Huang, X. R., Chung, A. C. K., Wang, W., Truong, L. D., & Lan, H. Y. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070762 · Cited by 271
Deshotels, M. R., Xia, H., Sriramula, S., Lazartigues, E., & Filipeanu, C. M. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03743 · Cited by 264
Jimenez-Guardeño, J. M., Nieto-Torres, J. L., DeDiego, M. L., Regla-Nava, J. A., Fernandez-Delgado, R., Castaño-Rodriguez, C., & Enjuanes, L. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004320 · Cited by 250
O’Donoghue, M. L., Glaser, R., Cavender, M. A., Aylward, P. E., Bonaca, M. P., Budaj, A., Davies, R. Y., Dellborg, M., Fox, K. A. A., Gutierrez, J. A. T., et al. (2016) · JAMA · doi:10.1001/jama.2016.3609 · Cited by 249
Kopecky-Bromberg, S. A., Martinez-Sobrido, L., & Palese, P. (2006) · Journal of Virology · doi:10.1128/jvi.80.2.785-793.2006 · Cited by 165
Marchant, D., Singhera, G. K., Utokaparch, S., Hackett, T. L., Boyd, J. H., Luo, Z., Si, X., Dorscheid, D. R., McManus, B. M., & Hegele, R. G. (2010) · Journal of Virology · doi:10.1128/jvi.00804-10 · Cited by 160
Marber, M. S., Rose, B., & Wang, Y. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.021 · Cited by 158
Immunologic Effects of the Renin-Angiotensin System
Crowley, S. D., & Rudemiller, N. P. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101066 · Cited by 156
Boergeling, Y., Schmolke, M., Viemann, D., Nordhoff, C., Roth, J., & Ludwig, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.469239 · Cited by 142
Zhang, P., Zhu, L., Cai, J., Lei, F., Qin, J., Wang, Y., Yuan, Y., Loomba, R. S., Liu, P. P., & Li, H. (2020) · Circulation Research · doi:10.1161/circresaha.120.317242 · Cited by 136
Scott, A. J., O'Dea, K. P., O’Callaghan, D. J., Williams, L. M., Dokpesi, J. O., Tatton, L., Handy, J. M., Hogg, P. J., & Takata, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277434 · Cited by 129
Ma, Q., Pan, W., Li, R., Liu, B., Li, C., Xie, Y., Wang, Z., Zhao, J., Jiang, H., Huang, J., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104850 · Cited by 120
Cheriyan, J., Webb, A. J., Sarov‐Blat, L., Elkhawad, M., Wallace, S. M. L., Maki-Petaja, K. M., Collier, D., Morgan, J., Fang, Z., Willette, R. N., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.971986 · Cited by 102
Fang, W., Cai, S., Wang, C., Sun, X., Li, K., Yan, X., Sun, Y., Sun, X., Gu, C.-K., Dai, M., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7811 · Cited by 71
Xiao, L., Haack, K., & Zucker, I. H. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00364.2012 · Cited by 65
Yu, X., Cui, L., Hou, F., Liu, X., Wang, Y., Wen, Y., Chi, C., Li, C., Liu, R., & Yin, C. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3252 · Cited by 56
Christie, J. D., Vaslef, S. N., Chang, P. K., May, A. K., Gunn, S. R., Yang, S., Hardes, K., Kahl, L. P., Powley, W. M., Lipson, D. A., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001132 · Cited by 42
Barbour, A., Sarov‐Blat, L., Cai, G., Fossler, M. J., Sprecher, D. L., Graggaber, J., McGeoch, A. T., Maison, J., & Cheriyan, J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12063 · Cited by 26
Chen, X., Tao, T., Wang, H., et al. (2018) · Medical Science Monitor · doi:10.12659/msm.909641 · Cited by 26
Cited by
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Ahern, D. J., Ai, Z., Ainsworth, M., Allan, C., Allcock, A., Angus, B., Ansari, M. A., Arancibia-Cárcamo, C. V., Aschenbrenner, D., Attar, M., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.012 · Cited by 328
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
Hariharan, A., Hakeem, A. R., Radhakrishnan, S., Reddy, M. S., & Rela, M. (2021) · Inflammopharmacology · doi:10.1007/s10787-020-00773-9 · Cited by 295
Metadata
- Authors
- Grimes, J. M., & Grimes, K. V.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 144
- Pages
- 63-65
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W3025943349
- Cited by
- 259
- References
- 31
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.